AbbVie (ABBV) EBIT Margin (2012 - 2026)
AbbVie's EBIT Margin came in at 36.01% for Q3 2026, up 23.94 percentage points from 12.07% a year earlier but down 1.85 percentage points from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) EBIT Margin (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, AbbVie reported EBIT Margin of 32.16%, up 17.01 percentage points year-over-year; for FY2025, it was 24.65%, up 8.43 percentage points from FY2024.
- EBIT Margin carries a five-year change of -0.16 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was 16.22% in FY2024 (-7.27 pp), 23.49% in FY2023 (-7.72 pp), 31.21% in FY2022 (-0.69 pp) and 31.89% in FY2021 (+7.09 pp).
- The five-year range for quarterly EBIT Margin is -9.87% (Q4 2024) to 37.86% (Q2 2026).
- Year-over-year, EBIT Margin increased in five of the last eight quarters, with an average year-over-year change of +3.57 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q4 2025 (a gain of 37.21 percentage points), and the weakest in Q4 2024 (a drop of 32.21 percentage points).
- Business Quant data shows ABBV's EBIT Margin at 37.86% (Q2 2026), 26.60% (Q1 2026) and 27.34% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 32.98% |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 20.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 36.01% |
| Jun 30, 2026 | 37.86% |
| Mar 31, 2026 | 26.60% |
| Dec 31, 2025 | 27.34% |
| Sep 30, 2025 | 12.07% |
| Jun 30, 2025 | 31.73% |
| Mar 31, 2025 | 27.98% |
| Dec 31, 2024 | -9.87% |
| Sep 30, 2024 | 26.49% |
| Jun 30, 2024 | 27.64% |
| Mar 31, 2024 | 22.73% |
| Dec 31, 2023 | 22.34% |
| Sep 30, 2023 | 16.38% |
| Jun 30, 2023 | 32.55% |
| Mar 31, 2023 | 22.64% |
| Dec 31, 2022 | 36.39% |
| Sep 30, 2022 | 31.08% |
| Jun 30, 2022 | 22.59% |
| Mar 31, 2022 | 34.84% |
| Dec 31, 2021 | 34.09% |
API Access
AbbVie EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();